Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis

Ropeginterferon alfa-2b is a novel mono-pegylated and extra-long-acting interferon, being developed for the treatment of myeloproliferative neoplasm (MPN) and chronic viral hepatitis. It has a favorable pharmacokinetic profile and less frequent dosing schedule, i.e., once every two to four weeks, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yi-Wen, Qin, Albert, Tsai, Chan-Yen, Chen, Pei-Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230558/
https://www.ncbi.nlm.nih.gov/pubmed/35746606
http://dx.doi.org/10.3390/v14061128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230558/
https://www.ncbi.nlm.nih.gov/pubmed/35746606
http://dx.doi.org/10.3390/v14061128

Ejemplares similares